The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease
Abstract
Alzheimer disease (AD) is the leading cause of dementia that affects millions of old people. Despite significant advances in the understanding of AD pathobiology, no disease modifying treatment is available. MicroRNA‐124 (miR‐124) is the most abundant miRNA in the normal brain with great potency to ameliorate AD‐like pathology, while it is deficient in AD brain. Herein, the authors develop a DNA nanoflowers (DFs)‐based delivery system to realize exogenous supplementation of miR‐124 for AD therapy. The DFs with well‐controlled size and morphology are prepared, and a miR‐124 chimera is attached via hybridization. The DFs are further modified with RVG29 peptide to simultaneously realize brain‐blood barrier (BBB) penetration and neuron targeting. Meanwhile, Rutin, a small molecular ancillary drug, is co‐loaded into the DFs structure via its intercalation into the double stranded DNA region. Interestingly, Rutin could synergize miR‐124 to suppress the expression of both BACE1 and APP, thus achieving a robust inhibition of amyloid β generation. The nanosystem could pro‐long miR‐124 circulation in vivo, promote its BBB penetration and neuron targeting, resulting in a significant increase of miR‐124 in the hippocampus of APP/PS1 mice and robust therapeutic efficacy in vivo. Such a bio‐derived therapeutic system shows promise as a biocompatible nanomedicine for AD therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Delivering miR-124 and rutin, a small molecular ancillary drug, to the brain of AD mice significantly increased miR-124 and inhibited the expression of BACE1 and APP [103].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [103]
In the citing paper
“miR-124 was downregulated in AD patients [103] (as listed in Table 6).”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [103]
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579
Song, Y., Li, Z., He, T., Qu, M., Jiang, L., Li, W., Shi, X., Pan, J., Zhang, L., Wang, Y., et al. (2019) · Theranostics · doi:10.7150/thno.30879 · Cited by 487
Alterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression
Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., & De Strooper, B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.009 · Cited by 436
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Ricciarelli, R., & Fedele, E. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170116143743 · Cited by 380
Why animal studies are often poor predictors of human reactions to exposure
Bracken, M. B. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.08k033 · Cited by 362
Hippocampal LTP and contextual learning require surface diffusion of AMPA receptors
Penn, A. C., Zhang, C. L., Georges, F., Royer, L., Breillat, C., Hosy, E., Petersen, J. D., Humeau, Y., & Choquet, D. (2017) · Nature · doi:10.1038/nature23658 · Cited by 324
Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Research works printed but not linked: 67
- 10.1038/nrneurol.2017.111 · DOI · Paper page
- 10.1186/s13041-015-0163-5 · DOI
- 10.1371/journal.pone.0151397 · DOI
- 10.1021/acs.accounts.1c00055 · DOI
- 10.1038/s41582-018-0116-6 · DOI · Paper page
- 10.1016/j.trci.2017.10.005 · DOI
- 10.1038/nsmb.1552 · DOI
- 10.1016/j.siny.2012.07.008 · DOI
- 10.1007/s12035-017-0808-8 · DOI
- 10.3233/JAD-181053 · DOI · Paper page
- 10.1007/s12035-016-9845-y · DOI
- 10.18632/oncotarget.23119 · DOI · Paper page
- 10.1007/s11010-013-1800-x · DOI
- Yu B., 2018, Mol. Med. Rep., 17, 6736
- 10.1016/j.biopsych.2017.07.023 · DOI
- 10.1007/s11010-018-3367-z · DOI
- 10.1126/science.1163728 · DOI
- 10.1016/j.jconrel.2019.10.007 · DOI
- 10.1016/j.ijpharm.2019.118449 · DOI
- 10.1080/10717544.2020.1760960 · DOI
- 10.3390/molecules25081929 · DOI
- 10.1016/S0079-6123(09)17903-7 · DOI
- 10.1038/nprot.2015.078 · DOI
- 10.1021/acsami.5b06987 · DOI
- 10.1016/j.biomaterials.2020.120221 · DOI
- 10.1002/smll.202104722 · DOI
- 10.1016/j.biomaterials.2020.120591 · DOI
- 10.1038/nmat3253 · DOI
- 10.1021/acsami.9b18282 · DOI
- Iaboni M., 2016, Mol. Med. Rep., 5
- 10.3892/mmr.2020.11253 · DOI
- 10.1016/j.bbr.2014.02.002 · DOI
- 10.1021/ja406115e · DOI
- 10.1007/s11095-012-0958-3 · DOI
- 10.1038/s41557-018-0209-2 · DOI
- 10.1038/npp.2017.167 · DOI
- 10.1002/adma.202006483 · DOI
- 10.1002/anie.202002312 · DOI
- 10.1007/s00216-016-9313-6 · DOI
- 10.1016/j.biomaterials.2015.11.060 · DOI
- 10.1016/j.bioactmat.2020.08.017 · DOI
- 10.1039/D0RA07161G · DOI
- 10.1016/j.mattod.2020.02.001 · DOI
- 10.1038/sj.bjp.0704508 · DOI
- Chalatsa I., 2019, Front. Neurosci., 13
- 10.1001/jamaneurol.2013.5847 · DOI
- 10.1016/j.phymed.2016.07.007 · DOI
- 10.1016/j.toxlet.2017.08.082 · DOI
- 10.1016/j.biopha.2018.12.074 · DOI · Paper page
- 10.1007/s10571-014-0073-6 · DOI
- 10.1021/acs.chemrev.7b00161 · DOI
- 10.1186/s12951-020-00766-4 · DOI
- 10.1007/s10456-017-9568-3 · DOI
- 10.1016/j.biomaterials.2021.121065 · DOI
- 10.1523/JNEUROSCI.1521-05.2005 · DOI · Paper page
- 10.3233/JAD-2011-101629 · DOI
- 10.1016/j.neuro.2012.03.003 · DOI
- 10.1126/sciadv.aau6328 · DOI
- 10.1038/cr.2013.116 · DOI · Paper page
- 10.1007/s11064-019-02931-0 · DOI
- 10.1038/s41392-019-0061-x · DOI · Paper page
- 10.1186/s12974-021-02182-3 · DOI
- 10.1007/s10565-007-9017-y · DOI
- 10.1016/j.biomaterials.2011.02.006 · DOI
- 10.1016/j.bios.2019.111788 · DOI
- 10.1016/j.jconrel.2017.03.390 · DOI
- 10.1186/s40478-019-0865-5 · DOI
Cited by
Sorted by citations
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
Li, W., & Zheng, Y. (2023) · Cells · doi:10.3390/cells12101378 · Cited by 43
Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy
Xi, Y., Chen, Y., Jin, Y., Han, G., Song, M., Song, T., Shi, Y., Tao, L., Huang, Z., Zhou, J., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.034 · Cited by 27
Metadata
- Authors
- Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J.
- Affiliations
- Hunan Province Key Laboratory of Brain Homeostasis Third Xiangya Hospital Central South University Changsha Hunan 410013 P. R. China
- Xiangya School of Pharmaceutical Sciences Central South University Changsha Hunan 410013 China
- Department of Anesthesiology Third Xiangya Hospital Central South University Changsha Hunan 410013 P. R. China
- Department of Anatomy and Neurobiology Central South University Xiangya School of Medicine Changsha Hunan 410013 China
- Venue
- Small
- Publisher
- Wiley
- Published
- 2022-02-19
- Volume
- 18
- Issue
- 14
- ISSN
- 1613-6810
- 1613-6829
- Cited by
- 94
- References
- 16
- Language
- en
- Funders
- National Natural Science Foundation of China (81870861, 81471107, 21804144, U1903125, 82073799)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review